Latest news and press releases about IDEXX Laboratories, Inc. (IDXX): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors.
Price
| Price | $527.07 |
| Market Cap | $41.6B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 36.71 |
| Price / Book | 25.75 |
| EV / EBITDA | 25.84 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 71.96% |
| Return on Invested Capital | 40.94% |
| Return on Assets | 33.11% |
| Gross Margin | 62.45% |
| Operating Margin | 32.03% |
| Net Margin | 25.03% |
Related companies: A · ALNY · ARGX · BDX · CAH · COR · EW
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of IDXX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks